Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-07-29 Option Award | 2019-07-31 8:28 pm | N/A 2029-07-29 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Feinsod Matthew Exec. VP, Global Strat. & Dev. | 100,000 | $0 | 100,000 (Direct) | View |
| 2019-07-11 Option Award | 2019-07-15 4:45 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Feinsod Matthew Interim Chief Medical Officer | 2,000 | $0 | 56,052 (Direct) | View |
| 2019-07-11 Tax Withholding | 2019-07-15 4:45 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Feinsod Matthew Interim Chief Medical Officer | 592 | $3.75 | 56,052 (Direct) | View |
| 2019-06-11 Tax Withholding(A) | 2019-06-20 4:39 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Feinsod Matthew Interim Chief Medical Officer | 685 | $3.7 | 54,644 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-13 7:21 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Feinsod Matthew Interim Chief Medical Officer | 2,000 | $0 | 54,644 (Direct) | View |
| 2019-06-11 Tax Withholding | 2019-06-13 7:21 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Feinsod Matthew Interim Chief Medical Officer | 685 | $3.77 | 54,644 (Direct) | View |
| 2019-05-13 Tax Withholding(A) | 2019-05-20 4:02 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Feinsod Matthew Interim Chief Medical Officer | 685 | $4.06 | 53,329 (Direct) | View |
| 2019-05-13 Option Award | 2019-05-15 4:21 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Feinsod Matthew Interim Chief Medical Officer | 2,000 | $0 | 53,329 (Direct) | View |
| 2019-05-13 Tax Withholding | 2019-05-15 4:21 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Feinsod Matthew Interim Chief Medical Officer | 685 | $4.2 | 53,329 (Direct) | View |